Variation in Benzodiazepine and Antipsychotic Prescribing Among Hospice Agencies

Lauren B. Gerlach, Lan Zhang, Julie Strominger, Hyungjin Myra Kim, Joan Teno, Julie P.W. Bynum, Donovan T. Maust

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Benzodiazepines and antipsychotics are routinely prescribed for symptom management in hospice. There is minimal evidence to guide prescribing in this population, and little is known about how prescribing varies across hospice agencies. Objective: Examine patient- and hospice agency–level characteristics associated with incident prescribing of benzodiazepines and antipsychotics in hospice. Design: Retrospective cohort study of a 20% sample of Medicare beneficiaries newly enrolled in hospice. Participants: Medicare hospice beneficiaries ≥ 65 years old between 2014 and 2016, restricted to those without benzodiazepine (N = 169,688) or antipsychotic (N = 190,441) prescription fills in the 6 months before hospice enrollment. Main Measures: The primary outcome was incident (i.e., new) prescribing of a benzodiazepine or antipsychotic. A series of multilevel Cox regression models with random intercepts for hospice agency were fit to examine the association of incident benzodiazepine and antipsychotic prescribing with patient and hospice agency characteristics. Key Results: A total of 91,728 (54.1%) and 58,175 (30.5%) hospice beneficiaries were newly prescribed an incident benzodiazepine or antipsychotic. The prescribing rate of the hospice agency was the strongest predictor of incident prescribing: Compared to patients in bottom-quartile benzodiazepine-prescribing agencies, those in top-quartile agencies were 10.7 times more likely to be prescribed an incident benzodiazepine (adjusted hazard ratio [AHR] 10.7, 95% CI 10.1–11.3). For incident antipsychotic prescribing, patients in top-quartile agencies were 51.7 times more likely to receive an antipsychotic (AHR 51.7, 95% CI 44.3–60.4) compared to those in the bottom quartile. Results remained consistent accounting for comfort kit prescribing. Conclusions: The pattern of benzodiazepine or antipsychotic prescribing of a hospice agency strongly predicts whether a hospice enrollee is prescribed these medications, exceeding every other patient-level factor. While the appropriate level of prescribing in hospice is unclear, this variation may reflect a strong local prescribing culture across individual hospice agencies.

Original languageEnglish (US)
JournalJournal of general internal medicine
DOIs
StateAccepted/In press - 2022

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint

Dive into the research topics of 'Variation in Benzodiazepine and Antipsychotic Prescribing Among Hospice Agencies'. Together they form a unique fingerprint.

Cite this